ZURICH Aug 27 Europe's largest biotech company
Actelion said on Tuesday its chief financial officer Andrew
Oakley would be leaving the company next week to focus on other
Oakley, who has been with the company since 2003, will be
replaced by Andre Muller from Sept. 1. Muller was previously at
pharmaceutical and cosmetics group Pierre Fabre SA, acting as
chief financial officer in his most recent role.
Oakley, a UK and Australian citizen, had previously occupied
a senior finance role at management consulting, technology
services and outsourcing company Accenture.
A spokesman for Actelion said Oakley's departure was "a
(Reporting by Martin de Sa'Pinto; Editing by David Cowell)